Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44

Mise à jour : Il y a 5 ans
Référence : EUCTR2006-000813-39

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

-To compare the inhibition of platelet aggregation (IPA) to 20 µM adenosine diphosphate (ADP) measured at 6 hours (±30 minutes) after prasugrel 60 mg loading dose (LD) versus clopidogrel 600 mg LD in subjects in the “on treatment population” who did not receive a GPIIb/IIIa inhibitor. -To compare the IPA to 20 µM ADP measured after 14±2 days of prasugrel 10 mg daily maintenance dose (MD) versus the IPA after 14±2 days of clopidogrel 150 mg daily MD in the “on treatment population” who have received PCI (this includes subjects receiving clopidogrel and prasugrel in either order during the crossover phase).


Critère d'inclusion

  • subjects undergoing elective cardiac catheterization with planned percutaneous coronary intervention (PCI) with coronary stenting